Atlas Trials

TACE Combined With Methylcantharidimide Tablets in the Treatment of Large and Unresectable Hepatocellular Carcinoma

Clinical trial NCT03996681 · UNKNOWN

Trial details

NCT number
NCT03996681
Sponsor
Suzhou Municipal Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2019-07-20
Primary completion
2020-07-20
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.